Emily L Heil (Emily Heil)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Infectious Diseases

Candida Albicans

Top Venues

Open forum infectious diseases

Hepatology communications

Pharmacotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Emily L Heil
Put the Fluoroquinolone Down and No One Gets Hurt. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (1) (2024)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Emily L Heil
Put the Fluoroquinolone Down and No One Gets Hurt. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Francis Mupeta, Suilanji Sivile, Mona-Gekanju Toeque, Sombo Fwoloshi, Paul Msanzya Zulu, Duncan Chanda, Nyuma Mbewe, Mundia Mwitumwa, Chitalu Chanda, Nyakulira Kandiwo, Luunga M Ziko, Tilele Mwansa, Peter Matibula, Anchidinka Mugala, Edward C Traver, Emily L Heil, Devang M Patel, David J Riedel, Lottie M Hachaambwa, Lloyd Mulenga, Cassidy Wayne Claassen
The UTH-UMB Global Health Education Collaboration: Building a Bidirectional Exchange Based on Equity and Reciprocity. Annals of global health 89 (1) (2023)
Emily L Heil, Harpreet Kaur, Anthony Atalla, Sapna Basappa, Minu Mathew, Hyunuk Seung, J Kristie Johnson, Gregory M Schrank
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open forum infectious diseases 10 (12) (2023)
Emily L Heil, Harpreet Kaur, Anthony Atalla, Sapna Basappa, Minu Mathew, Hyunuk Seung, J Kristie Johnson, Gregory M Schrank
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open forum infectious diseases 10 (12) (2023)
Emily L Heil, Harpreet Kaur, Anthony Atalla, Sapna Basappa, Minu Mathew, Hyunuk Seung, J Kristie Johnson, Gregory M Schrank
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open forum infectious diseases 10 (12) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Emily L Heil, Harpreet Kaur, Anthony Atalla, Sapna Basappa, Minu Mathew, Hyunuk Seung, J Kristie Johnson, Gregory M Schrank
Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections. Open forum infectious diseases 10 (12) (2023)
Kaiyan Liu, Sydney Stern, Emily L Heil, Linhao Li, Rula Khairi, Scott Heyward, Hongbing Wang
Dexamethasone mitigates remdesivir-induced liver toxicity in human primary hepatocytes and COVID-19 patients. Hepatology communications 7 (3) (2023)
Katherine E Goodman, Emily L Heil, Kimberly C Claeys, Mary Banoub, Jacqueline T Bork
Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention "Hotspots" in an Antibiotic Audit and Feedback Program. Open forum infectious diseases 9 (7) (2022)
Edward Conan Traver, Emily L Heil, Sarah A Schmalzle
A Cross-sectional Analysis of Linezolid in Combination with Methadone or Buprenorphine as a Cause of Serotonin Toxicity. Open forum infectious diseases 9 (7) (2022)
Zachary Pek, Emily L Heil, Eleanor Wilson
Getting With the Times: A Review of Peripartum Infections and Proposed Modernized Treatment Regimens. Open forum infectious diseases 9 (9) (2022)
Marguerite L Monogue, Emily L Heil, Samuel L Aitken, Jason M Pogue
The role of tazobactam-based combinations for the management of infections due to extended-spectrum β-lactamase-producing Enterobacterales: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 41 (10) (2021)
James B Doub, Jacqueline T Bork, Emily L Heil, Kristen Stafford, Mary Banoub, John K Karwowski, Shahab Toursavadkohi
Effectiveness and Safety of Biodegradable Calcium Sulfate Antibiotic Beads as Adjuvant Therapy in Vascular Graft Infections. Open forum infectious diseases 8 (2) (2021)
Brenna M Roth, Alexandra Laps, Kaunda Yamba, Emily L Heil, J Kristie Johnson, Kristen Stafford, Lottie M Hachaambwa, Mox Kalumbi, Lloyd Mulenga, Devang M Patel, Cassidy Wayne Claassen
Antibiogram Development in the Setting of a High Frequency of Multi-Drug Resistant Organisms at University Teaching Hospital, Lusaka, Zambia. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Melanie T Rebechi, Emily L Heil, Paul M Luethy, Sarah Ann Schmalzle
Streptococcus pyogenes Infective Endocarditis-Association With Injection Drug Use: Case Series and Review of the Literature. Open forum infectious diseases 8 (6) (2021)
Emily L Heil, Samuel L Aitken, David E Nix, Richard Drew, Warren E Rose, Susan L Davis, Julie Ann Justo, Douglas N Fish, Jason M Pogue, null null
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper. Pharmacotherapy 40 (4) (2021)
Emily L Heil, Shyam Kottilil
The Goldilocks Time for Remdesivir - Is Any Indication Just Right? The New England journal of medicine 386 (4) (2021)
Ana Vega, Emily L Heil, Alison Blackman, Mary Banoub, J Kristie Johnson, Surbhi Leekha, Kimberly C Claeys
Reply to Letters to the Editor. Pharmacotherapy 40 (9) (2020)
Ana D Vega, Emily L Heil, Alison L Blackman, Mary Banoub, Jennifer Kristie Johnson, Surbhi Leekha, Kimberly C Claeys
Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection. Pharmacotherapy 40 (5) (2020)
James B Doub, Emily L Heil, Afua Ntem-Mensah, Renaldo Neeley, Patrick R Ching
Rifabutin Use in Staphylococcus Biofilm Infections: A Case Series. Antibiotics (Basel, Switzerland) 9 (6) (2020)
Leama Ajaka, Emily L Heil, Sarah Schmalzle
Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care. Antibiotics (Basel, Switzerland) 9 (10) (2020)
Kimberly C Claeys, Emily L Heil, Stephanie Hitchcock, J Kristie Johnson, Surbhi Leekha
Management of Gram-Negative Bloodstream Infections in the Era of Rapid Diagnostic Testing: Impact With and Without Antibiotic Stewardship. Open forum infectious diseases 7 (10) (2020)
Sari R Freedman, Bharath R Ravichandran, Brian M Masters, Jonathan S Bromberg, Abdolreza Haririan, Kapil K Saharia, Emily L Heil, Tracy M Sparkes
Clinical outcomes of valganciclovir prophylaxis in high-risk (D+/R-) renal transplant recipients experiencing delayed graft function. Transplant infectious disease : an official journal of the Transplantation Society 21 (4) (2019)